157 related articles for article (PubMed ID: 10489862)
1. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin.
De Lauretis A; De Capua B; Barbieri MT; Bellussi L; Passàli D
Scand Audiol; 1999; 28(3):139-43. PubMed ID: 10489862
[TBL] [Abstract][Full Text] [Related]
2. ABR obtained from time-efficient train stimuli for cisplatin ototoxicity monitoring.
Dille MF; Ellingson RM; McMillan GP; Konrad-Martin D
J Am Acad Audiol; 2013 Oct; 24(9):769-81. PubMed ID: 24224985
[TBL] [Abstract][Full Text] [Related]
3. Effect of protective agents against cisplatin ototoxicity.
Rybak LP; Husain K; Morris C; Whitworth C; Somani S
Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
[TBL] [Abstract][Full Text] [Related]
4. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
Stavroulaki P; Apostolopoulos N; Segas J; Tsakanikos M; Adamopoulos G
Int J Pediatr Otorhinolaryngol; 2001 May; 59(1):47-57. PubMed ID: 11376818
[TBL] [Abstract][Full Text] [Related]
5. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
[TBL] [Abstract][Full Text] [Related]
6. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
7. Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses.
Fausti SA; Frey RH; Henry JA; Olson DJ; Schaffer HI
J Am Acad Audiol; 1992 Nov; 3(6):397-404. PubMed ID: 1486202
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
[TBL] [Abstract][Full Text] [Related]
9. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin is ototoxic.
Kennedy IC; Fitzharris BM; Colls BM; Atkinson CH
Cancer Chemother Pharmacol; 1990; 26(3):232-4. PubMed ID: 2192812
[TBL] [Abstract][Full Text] [Related]
11. Selective inner hair cell ototoxicity induced by carboplatin.
Wake M; Takeno S; Ibrahim D; Harrison R
Laryngoscope; 1994 Apr; 104(4):488-93. PubMed ID: 8164491
[TBL] [Abstract][Full Text] [Related]
12. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
Waissbluth S; Del Valle Á; Chuang A; Becker A
Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats.
Paksoy M; Ayduran E; Sanlı A; Eken M; Aydın S; Oktay ZA
Med Oncol; 2011 Jun; 28(2):615-21. PubMed ID: 20300971
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin ototoxicity: the importance of baseline audiometry.
Nagy JL; Adelstein DJ; Newman CW; Rybicki LA; Rice TW; Lavertu P
Am J Clin Oncol; 1999 Jun; 22(3):305-8. PubMed ID: 10362343
[TBL] [Abstract][Full Text] [Related]
15. High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.
van der Hulst RJ; Dreschler WA; Urbanus NA
Ann Otol Rhinol Laryngol; 1988; 97(2 Pt 1):133-7. PubMed ID: 3281541
[TBL] [Abstract][Full Text] [Related]
16. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
17. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
Bokemeyer C; Berger CC; Hartmann JT; Kollmannsberger C; Schmoll HJ; Kuczyk MA; Kanz L
Br J Cancer; 1998 Apr; 77(8):1355-62. PubMed ID: 9579846
[TBL] [Abstract][Full Text] [Related]
18. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cisplatin-induced ototoxicity using derived-band ABRs.
Coupland SG; Ponton CW; Eggermont JJ; Bowen TJ; Grant RM
Int J Pediatr Otorhinolaryngol; 1991 Oct; 22(3):237-48. PubMed ID: 1752735
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]